Volume 18, Issue 2 (10-2008)                   JHNM 2008, 18(2): 23-31 | Back to browse issues page

XML Print


1- , Farmanbar@gums.ac.ir
Abstract:   (5511 Views)

Introduction: Coronary artery angiography is an important diagnostic method in patients with ‎coronary disease which like other diagnostic methods has side effects. The important ‎complication of it is vascular side effects (hematoma and bleeding) in place of sheet insertion. ‎In order to control it, one must be in complete bed rest (CBR) and in no reference an exact ‎time is mentioned for it.

‎ Objective: This study was conducted to determine the effect of CBR duration on vascular ‎complication after angiography.

‎ Methods: This is a clinical trial method with random sampling. ‎‏120‏‎ patients were divided into ‎two groups of experiment (‎‏2‏‎ hour CBR) and the control group (‎‏6‏‎ hours CBR) and were ‎compared regarding vascular side effects. Arterial sheet was removed in both groups ‎immediately after patients transfer to post-angio and maintaining primary hemostasis by ‎applying manual pressure with a transparent dressing for observation. Vascular complications ‎were controlled in both groups up to ‎‏24‏‎ hours after procedure. ‎

Results: Findings revealed that both groups were matched regarding age, sex, BMI, sheet ‎size, coagulation tests, and length of manual pressure and duration of angiography. There was ‎no significant statistical difference in rate of vascular complications in both groups. ‎

Conclusion: It is possible to take patient out of CBR after two hours past angiography done ‎through femor. Implementing this method of care can shorten the time of hospitalization, ‎provide more comfort to the patient, decrease bed occupancy and decrease costs.‎

Full-Text [PDF 182 kb]   (2604 Downloads) |   |   Full-Text (HTML)  (1252 Views)  
Article Type : Research | Subject: Special
Received: 2014/08/23 | Accepted: 2014/08/23 | Published: 2014/08/23

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.